Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
VHT
417
HOLDINGS
6%
ALSO IN MEDX
MEDX
27
HOLDINGS
78%
ALSO IN VHT
SECTOR DRIFT (VHT minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.6% | 16.7% | 12.6% |
|
ABBVIE INC | 6.1% | 8.4% | 6.1% |
|
JOHNSON & JOHNSON | 8.8% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 4.6% | 3.9% | 3.9% |
|
AMGEN INC | 3.1% | 4.3% | 3.1% |
VHT Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 4.0% |
|
JOHNSON & JOHNSON | 3.1% |
|
ABBOTT LABORATORIES | 3.0% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
GILEAD SCIENCES INC | 2.7% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
DANAHER CORP | 2.0% |
|
STRYKER CORP | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.9% |
 |
MEDTRONIC PLC | 1.9% |
VHT Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -7.7% |
 |
ASTRAZENECA PLC | -5.7% |
|
IONIS PHARMACEUTICALS, INC. | -4.6% |
|
ELI LILLY & CO | -4.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
|
ALKERMES PLC | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -3.1% |
|
CRISPR THERAPEUTICS AG | -3.0% |
|
BIOGEN IDEC INC | -2.4% |